Skip to main content

LIV Capsules are proven to stimulate Th17

APCO scientists came up with LIV capsules which are formulated from plant extracts and have been proven to stimulate Th17, Th1 and Th9 by 5, 2 and 2 folds respectively.

All the stimulated Th cells increase the activities of natural killer cells and cytotoxic T-cells that eliminate HIV.

Results of the LIV efficiency test carried out at the Biomedical Technology Research Centre, Chiang Mai University

Healthy volunteers were given 4 LIV capsules a day for 15 days. This resulted in:

  • a doubling of their Th1 and Th9 activity.
  • a five times increase in their Th17 activity.
Thus strengthening of the immune system and signifying the potential to help control the HIV virus.

Scientific Study of The Effects of LIV, 4 Capsules a day for 15 days

LIV Capsules are proven to stimulate Th17

Previous research findings

GM-1 in the mangosteen extract used in the LIV capsule inhibits reverse transcriptase and protease enzymes which are essential in the virus replication process.

Source: National Library of Medicine Planta Med. 1996. Aug 62(4):381-2

Test Results of Tests on the Use of LIV Capsules by HIV-Affected Persons

A research study conducted by Prof. Dr. Watchara Kasinrerk (APCO Chair Professor) and Nopporn Pattanapornpun, MD. (Director of Mae-On hospital in Chiang Mai), showed that the CD4 cell count in HIV patients increased after taking 4 LIV capsules daily for 6-9 months.

APCO has since donated a life-time supply of LIV capsules to the 27 volunteers who took part in this research study.

APCO has given LIV capsules to HIV-infected volunteers in Chiang Mai who have been taking antiretroviral drugs for two years with the following results:

  • Their quality of life has improved significantly.
  • Those suffering from opportunistic infection such as viral infection, tuberculosis and pneumonia saw their symptoms remedied.
APCO has since donated a life-time supply of LIV capsules
to the 25 volunteers who took part in this research study.

LIV Capsules are proven to stimulate Th17

At Baan Gerda Children’s Rights Foundation, APCO has given LIV capsules to HIV-infected children who were taking antiretroviral drugs and suffering from opportunistic diseases.

Test Results of Tests on the Use of LIV Capsules by HIV-Affected Patients:

  • After taking 4 LIV capsules a day for 12 months, the opportunistic diseases symptoms were remedied and their CD4 count increased by an average of 67.34%.
  • A group of children who were already taking antiretroviral drugs but whose CD4 count had not increased for the previous 6 months had an average increase of 32.45% in their CD4 count after taking 9 LIV capsules a day for 3 months.
APCO has since donated a life-time supply of LIV capsules to all the 70 children at Baan Gerda infected with HIV.